| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2766363 | Medicina Paliativa | 2014 | 4 Pages |
Abstract
The management of death rattle in patients with terminal myasthenia gravis can be quite complex. Drugs regularly employed to reduce disturbing noisy respiratory secretions (hyoscine hydrobromide, hyoscine butylbromide, etc.) could trigger a myasthenia crisis due to their anti -cholinergic effects. We report a case treated by our team with octreotide, and discuss potential indications in this setting.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Ángela Ruiz de Temiño de la Peña, Judith Gil DomÃnguez, Coro Pérez Aznar, Juan Manuel Núñez Olarte,